Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 13, 2014, Pages 5137-5142

  Hu, Qing ^a   Gong, Jian Ping ^a   Li, Jian ^a   Zhong, Shan Liang ^a   Chen, Wei Xian ^a   Zhang, Jun Ying ^a   Ma, Teng Fei ^a   Ji, Hao ^a   Lv, Meng Meng ^a   Zhao, Jian Hua ^a   Tang, Jin Hai ^a  

^a JIANGSU CANCER HOSPITAL   (China)

Author keywords

Adriamycin; Breast cancer; Chemosensitivity; IGF 1R; MicroRNA 452

Indexed keywords

DOXORUBICIN; MICRORNA; MIRN452 MICRORNA, HUMAN; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; BREAST NEOPLASMS; DOWN REGULATION; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MCF 7 CELL LINE; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICRORNAS; RECEPTOR, IGF TYPE 1;

EID: 84905365381     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.13.5137     Document Type: Article

References (22)

1. Anaya-Ruiz M, Cebada J, Delgado-Lopez G, et al (2013). miR-153 silencing induces apoptosis in the MDA-MB-231 breast cancer cell line. Asian Pac J Cancer Prev, 14, 2983-6.
2. Anglicheau D, Muthukumar T, Suthanthiran M (2010). MicroRNAs: small RNAs with big effects. Transplantation, 90, 105-12.
3. Barrett SV (2010). Breast cancer. J R Coll Physicians Edinb, 40, 335-8.
4. Beech DJ, Parekh N, Pang Y (2001). Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and taxol. Oncol Rep, 8, 325-9.
5. Chen J, Tian W, Cai H, et al (2012). Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol, 29, 2527-34.
6. Haenisch S, Cascorbi I (2012). miRNAs as mediators of drug resistance. Epigenomics, 4, 369-81.
7. Howe EN, Cochrane DR, Richer JK (2011). Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res, 13, R45.
8. John B, Enright AJ, Aravin A, et al (2004). Human MicroRNA targets. PLoS Biol, 2, e363.
9. Jurmeister S, Baumann M, Balwierz A, et al (2012). MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol Cell Biol, 32, 633-51.
10. Kovalchuk O, Filkowski J, Meservy J, et al (2008). Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther, 7, 2152-9.
11. Kutanzi KR, Yurchenko OV, Beland FA, et al (2011). MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics, 2, 171-85.
12. Li JY, Zhang Y, Zhang WH, et al (2013a). Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis. Asian Pac J Cancer Prev, 14, 1715-20.
13. Li JY, JiaS, Zhang WH, et al (2013b). Differential distribution of microRNAs in breast cancer grouped by clinicopathological subtypes. Asian Pac J Cancer Prev, 14, 3197-203.
14. Li XJ, Ji MH, Zhong SL, et al (2012). MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1. Arch Med Res, 43, 514-21.
15. Peruzzi F, Prisco M, Dews M, et al (1999). Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol, 19, 7203-15.
16. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
17. Tian W, Chen J, He H, et al (2013). MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications. Clin Transl Oncol, 15, 335-42.
18. Tryndyak VP, Beland FA, Pogribny IP (2010). E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer, 126, 2575-83.
19. Wang ZX, Lu BB, Wang H, et al (2011). MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res, 42, 281-90.
20. Xiong L, Kou F, Yang Y, et al (2007). A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop. J Cell Biol, 178, 995-1007.
21. Zeng X, Zhang H, Oh A, et al (2012). Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor. Breast Cancer Res Treat, 133, 117-26.
22. Zhong S, Li W, Chen Z, et al (2013). MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Gene, 531, 8-14.